Segment, Customer and Geographical Reporting (Tables)

6 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The Company’s segment information for the three months ended March 31, 2018 and 2017 is summarized below:

Results of Operations for the Three Months Ended March 31,

2018 

	Optics			Contract  Research			Biomedical		Total
Revenue	$	5,910,000		$	4,345,000		$	-	$	10,255,000
Gross profit		2,050,000			1,895,000			-		3,945,000
GM %		35	%		44	%		-		38	%
Operating expenses		1,858,000			1,813,000			194,000		3,865,000
Operating income (loss)		192,000			82,000			(194,000)		80,000
Depreciation and amortization		247,000			61,000			3,000		311,000
Capital expenditures		339,000			58,000			29,000		426,000
Intangibles, net		455,000			179,000			363,000		997,000
Goodwill		1,070,000			4,939,000			-		6,009,000
Total assets	$	20,903,000		$	8,028,000		$	586,000	$	29,517,000

Results of Operations for the Three Months Ended March 31,

2017 

	Optics			Contract  Research			Biomedical		Total
Revenue	$	5,281,000		$	4,804,000		$	-	$	10,085,000
Gross profit		1,913,000			1,875,000			-		3,788,000
GM %		36	%		39	%		-		38	%
Operating expenses		1,597,000			1,802,000			392,000		3,791,000
Operating income (loss)		316,000			73,000			(392,000)		(3,000)
Depreciation and amortization		237,000			73,000			3,000		313,000
Capital expenditures		103,000			34,000			44,000		181,000
Intangibles, net		465,000			213,000			379,000		1,057,000
Goodwill		899,000			4,939,000			-		5,838,000
Total assets	$	19,705,000		$	7,477,000		$	794,000	$	27,976,000

The Company’s segment information for the six months ended March 31, 2018 and 2017 is summarized below:

Results of Operations for the Six Months Ended March 31,
2018
	Optics			Contract  Research			Biomedical		Total
Revenue	$	10,853,000		$	8,590,000		$	-	$	19,443,000
Gross profit		3,740,000			3,745,000			-		7,485,000
GM %		34	%		44	%		-		38	%
Operating expenses		3,433,000			3,537,000			639,000		7,609,000
Operating income (loss)		307,000			208,000			(639,000)		(124,000)
Depreciation and amortization		477,000			126,000			7,000		610,000
Capital expenditures		928,000			77,000			45,000		1,050,000
Intangibles, net		455,000			179,000			363,000		997,000
Goodwill		1,070,000			4,939,000			-		6,009,000
Total assets	$	20,903,000		$	8,028,000		$	586,000	$	29,517,000

Results of Operations for the Six Months Ended March 31,
2017
	Optics			Contract  Research			Biomedical		Total
Revenue	$	9,686,000		$	9,542,000		$	-	$	19,228,000
Gross profit		3,487,000			3,826,000			-		7,313,000
GM %		36	%		40	%		-		38	%
Operating expenses		2,924,000			3,542,000			773,000		7,239,000
Operating income (loss)		563,000			284,000			(773,000)		74,000
Depreciation and amortization		471,000			147,000			6,000		624,000
Capital expenditures		194,000			34,000			64,000		292,000
Intangibles, net		465,000			213,000			379,000		1,057,000
Goodwill		899,000			4,939,000			-		5,838,000
Total assets	$	19,705,000		$	7,477,000		$	794,000	$	27,976,000

Schedule Of Segment Revenue By Geographical Location [Table Text Block]

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended March 31, 2018 and 2017 are as follows:

	Three Months Ended					Three Months Ended
	March 31, 2018					March 31, 2017
Geographic Location	Revenue		%  of Total			Revenue		%  of Total
United States	$	8,129,000		79	%	$	7,931,000		79	%
Europe		1,365,000		13	%		1,212,000		12	%
Other		761,000		8	%		942,000		9	%
	$	10,255,000		100	%	$	10,085,000		100	%

Revenue by geographic location in total and as a percentage of total revenue, for the six months ended March 31, 2018 and 2017 are as follows:

	Six Months Ended					Six Months Ended
	March 31, 2018					March 31, 2017
Geographic Location	Revenue		% of Total			Revenue		%  of Total
United States	$	15,481,000		80	%	$	15,120,000		79	%
Europe		2,633,000		13	%		2,299,000		12	%
Other		1,329,000		7	%		1,809,000		9	%
	$	19,443,000		100	%	$	19,228,000		100	%